Bangkok Lab And Cosmetic Balance Sheet Health
Financial Health criteria checks 5/6
Bangkok Lab And Cosmetic has a total shareholder equity of THB1.6B and total debt of THB156.8M, which brings its debt-to-equity ratio to 9.6%. Its total assets and total liabilities are THB2.2B and THB583.3M respectively. Bangkok Lab And Cosmetic's EBIT is THB225.4M making its interest coverage ratio 16.4. It has cash and short-term investments of THB825.6M.
Key information
9.6%
Debt to equity ratio
฿156.78m
Debt
| Interest coverage ratio | 16.4x |
| Cash | ฿825.59m |
| Equity | ฿1.64b |
| Total liabilities | ฿583.30m |
| Total assets | ฿2.22b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BLC's short term assets (THB1.6B) exceed its short term liabilities (THB395.8M).
Long Term Liabilities: BLC's short term assets (THB1.6B) exceed its long term liabilities (THB187.5M).
Debt to Equity History and Analysis
Debt Level: BLC has more cash than its total debt.
Reducing Debt: Insufficient data to determine if BLC's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: BLC's debt is well covered by operating cash flow (122.2%).
Interest Coverage: BLC's interest payments on its debt are well covered by EBIT (16.4x coverage).